Evidence map›Paper›PMID 41025663›Full record

ArticleMicrobiology spectrum2025

Evaluation of an automated antimicrobial susceptibility testing system performance for colistin susceptibility in carbapenem-resistant

Arzu İlki, Fatih Mehmet Akıllı, Sevim Alpsoy Özsoy, Zeynep Saygı, İsmail Yüceel-Timur

Abstract readEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Arzu İlkiDepartment of Medical Microbiology, Marmara University School of Medicine, Istanbul, Turkey.ORCID 0000-0003-3887-7003
Fatih Mehmet AkıllıDepartment of Medical Microbiology, Marmara University School of Medicine, Istanbul, Turkey.ORCID 0000-0001-8541-7742
Sevim Alpsoy ÖzsoyMarmara University Pendik Research and Training Hospital, Microbiology Laboratory, Istanbul, Turkey.
Zeynep SaygıMarmara University School of Medicine, Istanbul, Turkey.
İsmail Yüceel-TimurGlobal Medical Affairs, bioMérieux, Marcy l'Étoile, France.

Funding

bioMerieux,France E0879
6 · The paper itself

Abstract

This study aims to assess the efficacy of VITEK 2 AST-XN21 (bioMérieux, Marcy l'Étoile, France) cards in identifying colistin susceptibility, comparing their performance with broth microdilution (BMD) results. A total of 187 carbapenem-resistant IMPORTANCE: Colistin resistance in carbapenem-resistant

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsCarbapenemsColistinAcinetobacter InfectionsDrug Resistance, BacterialHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsCarbapenemsColistinantimicrobial susceptibility testingbroth microdilutioncarbapenem-resistant Acinetobacter baumanniicolistin resistancemcr genesVITEK 2 AST-XN21

Identifiers

PMID41025663
PMCPMC12584677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.